When. Trials. Matter.

Our Therapeutic Areas

CNS diseases.  
Cardio metabolic.  
Infectious diseases.

Central Nervous System

CNS disease prevalence is rising, and available treatments for many are either minimally effective or nonexistent. CNS is one of the primary therapeutic areas where we have chosen to focus efforts. 

Read more

Cardio-metabolic

Julius Clinical’s focused approach has created a track record of excellence that testifies to our cardio-metabolic trial capabilities. We have honed our scientific site networks, collaborations with leading experts, and operational resources to deliver steady streams of patients and high-quality data for clients. 

Read more

Infectious Diseases & Vaccines

Unrecognised pathogens and reemerging infectious diseases are an ongoing threat to human health in every corner of the world. We contribute to important research in this area by conducting pioneering infectious disease and vaccine trials, doing what we do best: optimizing protocols and executing streamlined trials that deliver high-quality data.

Read more

Central Nervous System

CNS disease prevalence is rising, and available treatments for many are either minimally effective or nonexistent. CNS is one of the primary therapeutic areas where we have chosen to focus efforts. 

Read more

Cardio-metabolic

Julius Clinical’s focused approach has created a track record of excellence that testifies to our cardio-metabolic trial capabilities. We have honed our scientific site networks, collaborations with leading experts, and operational resources to deliver steady streams of patients and high-quality data for clients. 

Read more

Infectious Diseases & Vaccines

Unrecognised pathogens and reemerging infectious diseases are an ongoing threat to human health in every corner of the world. We contribute to important research in this area by conducting pioneering infectious disease and vaccine trials, doing what we do best: optimizing protocols and executing streamlined trials that deliver high-quality data.

Read more

Our track record

Discover our story

Our Unique Triangle

Our industry-leading combination of scientific leadership, site networks, and operational excellence forms the unique triangle that is the foundation of our success.

  • Webinars
  • Cardio-Metabolic Diseases, NASH
  • 23-05-2023

Upcoming webinar: Why NASH trials frequently fail and how to improve them

The upcoming NASH clinical webinar promises to be an insightful and informative session, with our scientific officer Manuel Castro Cabezas as the guest speaker. Manuel will be sharing his expertise on the topic of "Why NASH trials frequently fa...

Speakers: Prof. Manuel Castro Cabezas - Prof. dr. Christophe Moreno, M.D.

Upcoming webinar: Real-World Data in ALS

We are excited to invite you to our webinar exploring the innovative integration of Real World Data (RWD) in clinical trials for Amyotrophic Lateral Sclerosis (ALS). As a critical step forward in the pursuit of effective treatments and improved pa...

Download

"*" indicates required fields

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Request for proposal

"*" indicates required fields

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
This field is for validation purposes and should be left unchanged.

Share

Twitter Facebook LinkedIn